{
    "clinical_study": {
        "@rank": "152868", 
        "arm_group": [
            {
                "arm_group_label": "CBX129801 High Dose", 
                "arm_group_type": "Experimental", 
                "description": "Solution for injection, 2.4 mg, weekly for 52 weeks"
            }, 
            {
                "arm_group_label": "CBX129801 Low Dose", 
                "arm_group_type": "Experimental", 
                "description": "Solution for injection, 0.8 mg, weekly for 52 weeks"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Solution for injection, vehicle with no active, weekly for 52 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to determine the beneficial effects of CBX129801 (PEGylated\n      synthetic human C-peptide) following weekly subcutaneous administration for 12 months in\n      type 1 diabetes mellitus patients (T1DM) with mild to moderate diabetic peripheral\n      neuropathy (DPN)."
        }, 
        "brief_title": "Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetic Peripheral Neuropathy", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus, Type 1", 
                "Peripheral Nervous System Diseases", 
                "Diabetic Neuropathies"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Key Inclusion Criteria:\n\n          -  Give informed consent;\n\n          -  18-65 years old;\n\n          -  Have type 1 diabetes mellitus for a minimum of 5 years, with a stable diabetic\n             regimen (for at least 3 months);\n\n          -  Have clinical signs of diabetic peripheral neuropathy at screening;\n\n          -  Have abnormal sural nerve conduction observed bilaterally during screening;\n\n          -  Be C-peptide deficient;\n\n          -  Be in good general health (besides having type 1 diabetes mellitus);\n\n          -  Practice effective contraception during and for at least 12 weeks after study\n             participation;\n\n          -  Have a body mass index (BMI) \u226518.0 and <35.0 kg/m2.\n\n        Key Exclusion Criteria:\n\n          -  Any significant cardiovascular, hematological, lymphatic, immunologic, urologic,\n             dermatologic, psychiatric, renal, hepatic, pulmonary, endocrine (except for diabetes\n             mellitus), central nervous, gastrointestinal, or other major disease;\n\n          -  Unstable or inadequate glucose control;\n\n          -  Any clinically significant laboratory value at screening;\n\n          -  Occurrence of a severe, unexplainable hypoglycemic event (defined as requiring the\n             assistance of another individual) within 6 months of Day 0, or recurrent episodes of\n             non-severe hypoglycemia (\u22653 per week on average) that are deemed clinically\n             significant by the Investigator;\n\n          -  Have had an islet cell, kidney, and/or pancreas transplant;\n\n          -  If female, is pregnant or lactating;\n\n          -  History of alcohol or substance abuse within 2 years;\n\n          -  Positive screen for hepatitis B, hepatitis C antibody, or human immunodeficiency\n             virus (HIV) antibody;\n\n          -  Initiation of treatment or change of dose of medication that could affect peripheral\n             nerve function within 60 days;\n\n          -  Previous treatment with CBX129801 or unmodified C-peptide;\n\n          -  Receipt of an investigational product or therapeutic device, or participation in a\n             drug research study, within a period of 30 days;\n\n          -  Chronic use of oral steroids or use of Ampyra (dalfampridine) within 60 days."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01681290", 
            "org_study_id": "CBX129801-DN-201"
        }, 
        "intervention": {
            "arm_group_label": [
                "CBX129801 High Dose", 
                "CBX129801 Low Dose"
            ], 
            "intervention_name": "CBX129801", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "December 5, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Escondido", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92026"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fresno", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "93720"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Irvine", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92618"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90036"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92161"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94110"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90502"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tustin", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92780"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Walnut Creek", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94598"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30318"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Decatur", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30033"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Idaho Falls", 
                        "country": "United States", 
                        "state": "Idaho", 
                        "zip": "83404"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48109"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Butte", 
                        "country": "United States", 
                        "state": "Montana", 
                        "zip": "59701"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68131"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89102"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75230"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77074"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 2C4"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Laval", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H7T 2P5"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "G\u00f6teborg", 
                        "country": "Sweden", 
                        "zip": "413 45"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Link\u00f6ping", 
                        "country": "Sweden", 
                        "zip": "581 85"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malmo", 
                        "country": "Sweden", 
                        "zip": "20502"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "171 76"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Umea", 
                        "country": "Sweden", 
                        "zip": "90185"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada", 
                "Sweden"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CBX129801 (Ersatta\u2122), Long-Acting Synthetic C-Peptide, in Type 1 Diabetes Mellitus Subjects With Mild to Moderate Diabetic Peripheral Neuropathy", 
        "overall_official": {
            "affiliation": "Chief Medical Officer", 
            "last_name": "Dennis Kim, MD"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Bilateral change in sensory nerve conduction velocity", 
            "safety_issue": "No", 
            "time_frame": "Predose and 12 months post dose"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01681290"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Vibration perception threshold", 
                "safety_issue": "No", 
                "time_frame": "Predose and 6 and 12 months post dose"
            }, 
            {
                "measure": "Clinical composite score", 
                "safety_issue": "Yes", 
                "time_frame": "Predose and 6 and 12 months post dose"
            }, 
            {
                "measure": "Pain Intensity due to DPN", 
                "safety_issue": "No", 
                "time_frame": "Predose and 12 months post dose"
            }, 
            {
                "measure": "Sexual function questionnaires", 
                "safety_issue": "No", 
                "time_frame": "Predose and 6 and 12 months post dose"
            }, 
            {
                "measure": "Quality of life questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Predose and 12 months post dose"
            }
        ], 
        "source": "Cebix Incorporated", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cebix Incorporated", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}